Goeltz II Robert C. Insider Trading Activity

Average Profitability
33.11%
Insider Buys Quantity
1
Insider Buys Sum
$107,848.50
Insider Sells Quantity
7
Insider Sells Sum
$1.15M

Insider Activity of Goeltz II Robert C.

According to the SEC Form 4 filings, Goeltz II Robert C., being in a position of

  1. Chief Financial Officer at Arcus Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 31977 shares for $755,891,
    over all time since 2020-09-09, has bought 5000 shares for $107,849, and sold 50183 shares for $1.15M.

Biography of Goeltz II Robert C.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $755,8915100

Comparison of Insiders on Amount of Buys and Sells

2026-05-11SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
7,763
0.008%
$25.63$198,966+3.58%
2025-12-31SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
6,552
0.0061%
$23.38$153,186+1.26%
2025-12-17SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
5,960
0.0055%
$22.16$132,071+7.52%
2025-12-16SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
6,702
0.0061%
$21.88$146,669+7.84%
2025-11-26SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
5,000
0.0045%
$25.00$125,000-5.61%
2025-10-28SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
5,000
0.0056%
$20.00$100,000+19.87%
2024-12-31SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
3,594
0.004%
$15.00$53,910-29.55%
2024-01-02SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
2,004
0.0027%
$20.00$40,080-17.94%
2023-06-07SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
4,049
0.0054%
$20.04$81,142-15.96%
2022-12-16SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
2,453
0.0034%
$30.75$75,430-39.59%
2021-12-17SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
621
0.0009%
$40.36$25,061-33.15%
2021-12-16SaleArcus Biosciences, Inc.
RCUS
Chief Financial Officer
485
0.0007%
$39.83$19,315-29.33%
2020-09-09PurchaseArcus Biosciences, Inc.
RCUS
Chief Financial Officer
5,000
0.0079%
$21.57$107,849+33.11%
2017-03-20SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
43,034
0.1235%
$19.81$852,680-6.3%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.